Natera, INC Form 4 insider transactions
NASDAQ
NTRA
Natera, INCNatera Inc. reports insider Solomon Moshkevich sold 2,900 shares of common stock on July 1, 2026, as part of a pre-arranged trading plan.
NASDAQ
NTRA
Natera, INCNatera, Inc. reports that Director Eric H. Rubin was issued 75 Restricted Stock Units (RSUs) as compensation for his board services.
NASDAQ
NTRA
Natera, INCNatera, Inc. reports a Form 4 filing detailing transactions by Director Herm Rosenman, including the acquisition of restricted stock units and the disposal of common stock.
NASDAQ
NTRA
Natera, INCNatera, Inc. director Marcus Gail Boxer was issued restricted stock units (RSUs) and vested RSUs on June 26, 2026, as part of his compensation and service to the company.
NASDAQ
NTRA
Natera, INCNatera, Inc. reports that Director Thomas J. Lynch Jr. was granted Restricted Stock Units (RSUs) valued at $425,000, with vesting over three years.
NASDAQ
NTRA
Natera, INCNatera, Inc. reports that Director Rowan Chapman acquired restricted stock units (RSUs) and common stock on June 26, 2026.
NASDAQ
NTRA
Natera, INCNatera, Inc. director Roelof Botha has reported transactions involving restricted stock units (RSUs), including an issuance for services and a grant that vests in 2027.
NASDAQ
NTRA
Natera, INCNatera, Inc. reports that Director Monica Bertagnolli acquired restricted stock units (RSUs) as compensation for board services and in lieu of retainer fees.
NASDAQ
NTRA
Natera, INCNatera, Inc. Director Roy Baynes acquired restricted stock units (RSUs) as compensation for board services and in lieu of retainer fees.
NASDAQ
NTRA
Natera, INCNatera, Inc. reports that SEC and Chief Legal Officer Daniel Rabinowitz sold a significant number of shares under a pre-established trading plan.
NASDAQ
NTRA
Natera, INCNatera, Inc. Director Herm Rosenman sold 16,530 shares of common stock for $250 per share, totaling $4,132,500, as part of a pre-arranged trading plan.
NASDAQ
NTRA
Natera, INCNatera, Inc. Director Rowan E. Chapman sold 2,964 shares of common stock on June 16, 2026, pursuant to a Rule 10b5-1 trading plan.
NASDAQ
NTRA
Natera, INCNatera, Inc. Co-Founder Jonathan Sheena sold 3,150 shares of common stock via a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
NTRA
Natera, INCExecutive Chairman Matthew Rabinowitz sold 100,000 shares of Natera, Inc. common stock under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
NTRA
Natera, INCNatera, Inc. Director Gail Marcus exercised 11,000 stock options and subsequently sold the shares in a series of transactions.
NASDAQ
NTRA
Natera, INCCEO Steven Chapman liquidated 41,124 shares of Natera common stock through a series of transactions on June 4, 2026.
NASDAQ
NTRA
Natera, INCSolomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 3,000 shares of common stock via a Rule 10b5-1 trading plan.
NASDAQ
NTRA
Natera, INCNatera, Inc. director Eric H. Rubin was granted 2,124 restricted stock units as part of his compensation package.
NASDAQ
NTRA
Natera, INCNatera, Inc. Director Roelof Botha reported the sale of common stock totaling over 70,000 shares on June 1, 2026, with transactions executed at weighted average prices ranging from $218.27 to $224.11.
NASDAQ
NTRA
Natera, INCSolomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 1,652 shares of common stock to cover tax obligations.
NASDAQ
NTRA
Natera, INCNatera President and Chief Business Officer John Fesko sold 1,438 shares of common stock to cover tax obligations related to RSU vesting.
NASDAQ
NTRA
Natera, INCNatera co-founder Jonathan Sheena executed a series of stock sales totaling 5,006 shares under pre-established 10b5-1 trading plans.
NASDAQ
NTRA
Natera, INCExecutive Chairman Matthew Rabinowitz sold 7,708 shares of Natera, Inc. to satisfy tax withholding requirements following the vesting of restricted stock units.
NASDAQ
NTRA
Natera, INCNatera's Chief Financial Officer Michael Brophy sold 795 shares of common stock in early May 2026 for approximately 166,000 dollars.
NASDAQ
NTRA
Natera, INCNatera Co-Founder Jonathan Sheena sold 107 shares of common stock to satisfy tax obligations related to RSU vesting.
NASDAQ
NTRA
Natera, INCSolomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 3,405 shares of common stock to cover tax obligations and pursuant to a 10b5-1 trading plan.
NASDAQ
NTRA
Natera, INCJohn Fesko, President and Chief Business Officer of Natera, Inc., sold 291 shares of common stock to cover tax obligations.
NASDAQ
NTRA
Natera, INCNatera CEO Steven Chapman sold 902 shares of common stock to satisfy tax withholding obligations related to RSU vesting.
NASDAQ
NTRA
Natera, INCNatera's Chief Legal Officer Daniel Rabinowitz sold 330 shares of common stock to cover tax withholding requirements.
NASDAQ
NTRA
Natera, INCNatera's Chief Financial Officer Michael Brophy disposed of 5,063 shares through tax-related obligations and a pre-arranged trading plan.